Synovitis in osteoarthritis: the current state of the problem
The article presents current data on synovitis (inflammation of the synovial membrane), which is often the only clinical manifestation of osteoarthritis (OA), and considered to be one of the risk factors for the OA development. Synovitis severity correlates with the severity of OA symptoms. The asse...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-04-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1132 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849339259306115072 |
|---|---|
| author | I. S. Dydykina E. V. Arutyunova P. S. Kovalenko E. V. Nikolaeva A. V. Naumov |
| author_facet | I. S. Dydykina E. V. Arutyunova P. S. Kovalenko E. V. Nikolaeva A. V. Naumov |
| author_sort | I. S. Dydykina |
| collection | DOAJ |
| description | The article presents current data on synovitis (inflammation of the synovial membrane), which is often the only clinical manifestation of osteoarthritis (OA), and considered to be one of the risk factors for the OA development. Synovitis severity correlates with the severity of OA symptoms. The assessment of the prevalence of synovitis presents significant difficulties and depends on the nature and severity of the disease, the cohort in question, diagnostic method, and therapy. The classification based on etiological, clinical and histological characteristics of synovitis is presented. Examination of synovial tissue characteristics and its changes during inflammatory response can significantly expand the possibilities for therapy and prognosis. The use of symptomatic delayed-action drugs (SYSADOA) is considered as the basic treatment of OA. Chondroitin sulfate (Chondroquard®) is one of the well established drugs, it has symptom- and structural-modifying properties. The article presents the results of studies confirming its effectiveness in reducing the severity of knee synovitis. |
| format | Article |
| id | doaj-art-5c611d6e84d345b282ff2cb640146e8a |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2021-04-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-5c611d6e84d345b282ff2cb640146e8a2025-08-20T03:44:10ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2021-04-0115212012510.14412/1996-7012-2021-2-120-1252353Synovitis in osteoarthritis: the current state of the problemI. S. Dydykina0E. V. Arutyunova1P. S. Kovalenko2E. V. Nikolaeva3A. V. Naumov4V.A. Nasonova Research Institute of RheumatologyM.V. Lomonosov Moscow State UniversityV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyRussian Clinical and Research Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaThe article presents current data on synovitis (inflammation of the synovial membrane), which is often the only clinical manifestation of osteoarthritis (OA), and considered to be one of the risk factors for the OA development. Synovitis severity correlates with the severity of OA symptoms. The assessment of the prevalence of synovitis presents significant difficulties and depends on the nature and severity of the disease, the cohort in question, diagnostic method, and therapy. The classification based on etiological, clinical and histological characteristics of synovitis is presented. Examination of synovial tissue characteristics and its changes during inflammatory response can significantly expand the possibilities for therapy and prognosis. The use of symptomatic delayed-action drugs (SYSADOA) is considered as the basic treatment of OA. Chondroitin sulfate (Chondroquard®) is one of the well established drugs, it has symptom- and structural-modifying properties. The article presents the results of studies confirming its effectiveness in reducing the severity of knee synovitis.https://mrj.ima-press.net/mrj/article/view/1132osteoarthritisknee osteoarthritissynovial membranesynovitisdiagnosis of synovitisclassification of synovitistreatment of synovitischondroquard® |
| spellingShingle | I. S. Dydykina E. V. Arutyunova P. S. Kovalenko E. V. Nikolaeva A. V. Naumov Synovitis in osteoarthritis: the current state of the problem Современная ревматология osteoarthritis knee osteoarthritis synovial membrane synovitis diagnosis of synovitis classification of synovitis treatment of synovitis chondroquard® |
| title | Synovitis in osteoarthritis: the current state of the problem |
| title_full | Synovitis in osteoarthritis: the current state of the problem |
| title_fullStr | Synovitis in osteoarthritis: the current state of the problem |
| title_full_unstemmed | Synovitis in osteoarthritis: the current state of the problem |
| title_short | Synovitis in osteoarthritis: the current state of the problem |
| title_sort | synovitis in osteoarthritis the current state of the problem |
| topic | osteoarthritis knee osteoarthritis synovial membrane synovitis diagnosis of synovitis classification of synovitis treatment of synovitis chondroquard® |
| url | https://mrj.ima-press.net/mrj/article/view/1132 |
| work_keys_str_mv | AT isdydykina synovitisinosteoarthritisthecurrentstateoftheproblem AT evarutyunova synovitisinosteoarthritisthecurrentstateoftheproblem AT pskovalenko synovitisinosteoarthritisthecurrentstateoftheproblem AT evnikolaeva synovitisinosteoarthritisthecurrentstateoftheproblem AT avnaumov synovitisinosteoarthritisthecurrentstateoftheproblem |